Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina

NCT01549977 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Business Decision (please see below)

Conditions

Angina

Interventions

DRUG: Febuxostat
DRUG: Placebo

Sponsor

Takeda